Inmune Bio Income Statement (2017-2025) | INMB

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.00M0.01M0.16M0.16M0.02M0.10M0.10M0.04M0.05M0.04M0.03M0.01M0.05M
Operating items
Research & Development 0.10M0.29M0.10M0.29M2.49M4.46M6.52M7.07M4.31M4.19M5.16M3.41M4.13M4.15M5.99M6.01M8.69M7.05M10.07M7.35M7.64M5.80M4.89M
Selling, General & Administrative 2.74M5.89M1.81M1.68M2.06M2.09M2.52M2.12M2.33M2.21M2.38M2.33M2.33M2.31M2.59M2.40M2.34M2.81M2.22M2.11M2.32M2.25M2.55M
Other Operating Expenses -1.54M-0.01M-0.42M-0.11M-0.09M-0.01M0.12M16.51M
Operating Expenses 2.85M6.17M1.91M0.43M4.55M6.55M9.04M9.19M6.64M6.40M7.54M5.74M6.46M6.46M8.57M8.41M11.03M9.87M12.29M9.47M9.96M24.57M7.43M
Operating Income -2.85M-6.17M-1.91M-0.43M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
EBIT -2.85M-6.17M-1.91M-0.43M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Non-operating items
Interest & Investment Income 0.04M
Other Non Operating Income 0.01M0.04M-0.01M-0.01M0.17M
Non Operating Income 0.01M0.04M-0.01M0.10M0.44M0.64M0.42M0.45M0.28M-2.50M0.11M0.09M-0.04M-0.03M-0.01M0.12M0.19M0.25M0.17M0.11M0.96M
Net income details
EBT -2.85M-6.17M-1.91M-0.39M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Profit After Tax -2.85M-6.17M-1.90M-0.39M-4.56M-6.66M-9.46M-9.67M-6.90M-6.84M-7.72M-5.83M-6.54M-6.50M-8.56M-8.41M-11.03M-9.75M-12.09M-9.24M-9.74M-24.46M-6.47M
Income from Continuing Operations -2.85M-6.17M-1.91M-0.39M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Consolidated Net Income -2.85M-6.17M-1.91M-0.39M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Income towards Parent Company -2.85M-6.17M-1.91M-0.39M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Net Income towards Common Stockholders -2.85M-6.17M-1.91M-0.39M-4.55M-6.55M-9.02M-9.03M-6.48M-6.39M-7.44M-5.64M-6.42M-6.41M-8.53M-8.38M-11.02M-9.87M-12.29M-9.47M-9.90M-24.57M-7.43M
Additional items
EPS (Basic) -0.33-0.71-0.20-0.04-0.32-0.44-0.55-0.56-0.39-0.38-0.43-0.32-0.36-0.36-0.48-0.47-0.61-0.50-0.60-0.47-0.43-1.05-0.24
EPS (Weighted Average and Diluted) -0.52-0.56-0.36-0.36-0.41-0.31-0.36-0.36-0.48-0.47-0.61-0.50-0.60-0.47-0.43-1.05-0.24
Shares Outstanding (Weighted Average) 6.56M8.55M8.72M8.72M8.68M9.39M10.15M10.76M10.75M10.80M12.93M11.99M14.32M14.97M17.33M16.13M17.87M17.95M17.95M17.93M17.95M17.95M18.01M17.98M18.03M19.31M20.19M19.94M22.50M23.30M26.59M
Shares Outstanding (Diluted Average) 17.33M16.13M17.87M17.95M17.95M17.93M17.95M17.95M18.01M17.98M18.03M19.31M20.19M19.94M22.50M23.30M26.59M
EBITDA -2.83M-6.20M-1.90M-0.42M-4.55M-6.72M-9.53M-9.55M-6.85M-7.59M-8.17M-5.39M-6.54M-6.50M-8.59M-8.47M-10.89M-9.79M-12.42M-8.76M-9.77M-24.61M-6.47M